The public health value of vaccines beyond efficacy: methods, measures and outcomes
Assessments of vaccine efficacy and safety capture only the minimum information needed for regulatory approval, rather than the full public health value of vaccines. Vaccine efficacy provides a measure of proportionate disease reduction, is usually limited to etiologically confirmed disease, and foc...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
26 July 2017
|
| In: |
BMC medicine
Year: 2017, Jahrgang: 15, Pages: 1-9 |
| ISSN: | 1741-7015 |
| DOI: | 10.1186/s12916-017-0911-8 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12916-017-0911-8 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12916-017-0911-8 
|
| Verfasserangaben: | A. Wilder-Smith, I. Longini, P. L. Zuber, T. Bärnighausen, W. J. Edmunds, N. Dean, V. Masserey Spicher, M. R. Benissa and B. D. Gessner |
| Zusammenfassung: | Assessments of vaccine efficacy and safety capture only the minimum information needed for regulatory approval, rather than the full public health value of vaccines. Vaccine efficacy provides a measure of proportionate disease reduction, is usually limited to etiologically confirmed disease, and focuses on the direct protection of the vaccinated individual. Herein, we propose a broader scope of methods, measures and outcomes to evaluate the effectiveness and public health impact to be considered for evidence-informed policymaking in both pre- and post-licensure stages. |
|---|---|
| Beschreibung: | Gesehen am 02.02.2022 |
| Beschreibung: | Online Resource |
| ISSN: | 1741-7015 |
| DOI: | 10.1186/s12916-017-0911-8 |